CERS4 and infectious otitis media: Although the AOM dose was reduced to a double injection of 5 mg/kg, the following DSS application resulted in higher lethality in CerS4 KO (~62%) mice than in CerS4 WT (~13%) or the conditional CerS4 Cre mice (0%).